Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 83751-83800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05007990
Caregiving Networks Across Disease Context and the Life Course
N/A
Recruiting
2,800 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2030
5 conditions
1 sponsor
1 location
NCT06320626
Pharmacokinetic-guided Dosing of Emicizumab
PHASE4
Recruiting
95 participants
Started: Sep 8, 2022 · Completed: Aug 31, 2026
6 conditions
9 sponsors
8 locations
NCT05540782
A Study of Cognitive Health in Survivors of Prostate Cancer
N/A
Active, not recruiting
200 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2026
2 conditions
1 sponsor
7 locations
NCT05561829
Determination of Optimal Sleep Treatment Elements - MOST
NA
Active, not recruiting
489 participants
Started: Sep 8, 2022 · Completed: May 31, 2024
1 condition
3 sponsors
1 location
NCT05440838
Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
N/A
Not yet recruiting
120 participants
Started: Sep 8, 2022 · Completed: Oct 4, 2029
1 condition
6 sponsors
0 locations
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
PHASE3
Recruiting
1,594 participants
Started: Sep 8, 2022 · Completed: Apr 30, 2032
1 condition
2 sponsors
207 locations
NCT05619250
Supervised Center-based vs. Unsupervised Home-based Exercise Programs (PRO-Training)
NA
Recruiting
120 participants
Started: Sep 7, 2022 · Completed: Dec 20, 2024
3 conditions
3 sponsors
1 location
NCT05442203
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
NA
Active, not recruiting
1,000 participants
Started: Sep 7, 2022 · Completed: Jul 31, 2025
2 conditions
1 sponsor
3 locations
NCT05621759
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
PHASE2
Active, not recruiting
27 participants
Started: Sep 7, 2022 · Completed: Aug 23, 2026
1 condition
1 sponsor
1 location
NCT05264714
Cluster Headache Treatment With Rimegepant
PHASE2
Active, not recruiting
10 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05497531
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NA
Recruiting
15 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2025
6 conditions
1 sponsor
1 location
NCT05385549
5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
PHASE2
Recruiting
35 participants
Started: Sep 7, 2022 · Completed: Apr 30, 2030
1 condition
1 sponsor
1 location
NCT05388760
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
PHASE2
Active, not recruiting
24 participants
Started: Sep 7, 2022 · Completed: Apr 23, 2026
1 condition
1 sponsor
11 locations
NCT04996316
MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
N/A
Enrolling by invitation
1,141 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
1 condition
3 sponsors
1 location
NCT05618041
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
NA
Recruiting
50 participants
Started: Sep 7, 2022 · Completed: Dec 6, 2027
3 conditions
2 sponsors
1 location
NCT05556642
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
N/A
Recruiting
500 participants
Started: Sep 7, 2022 · Completed: Sep 1, 2040
2 conditions
1 sponsor
1 location
NCT05330338
Genetics of Ventriculo-arterial Discordance
NA
Recruiting
600 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2045
1 condition
4 sponsors
16 locations
NCT05563805
Exploring Virtual Reality Adventure Training Exergaming
NA
Recruiting
40 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
7 conditions
1 sponsor
1 location
NCT05534412
A Practice-Based Intervention to Improve Care for a Diverse Population of Women with Urinary Incontinence
NA
Recruiting
1,600 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition
6 sponsors
4 locations
NCT05213598
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
N/A
Recruiting
100 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2051
1 condition
1 sponsor
1 location
NCT05425940
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
PHASE3
Active, not recruiting
901 participants
Started: Sep 7, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
133 locations
NCT05470283
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
PHASE1
Active, not recruiting
21 participants
Started: Sep 7, 2022 · Completed: Apr 1, 2027
3 conditions
1 sponsor
1 location
NCT05761093
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
N/A
Recruiting
306 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05419037
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
N/A
Recruiting
90 participants
Started: Sep 7, 2022 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05322629
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
NA
Recruiting
650 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05424562
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
N/A
Recruiting
270 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
20 locations
NCT05621798
Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting
NA
Active, not recruiting
101 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT05412927
AngelMed Guardian® System PMA Post Approval Study
N/A
Recruiting
500 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
18 locations
NCT05277818
Post-marketing Clinical Follow-up of the Medical Device DIVA®
N/A
Recruiting
822 participants
Started: Sep 7, 2022 · Completed: Mar 15, 2027
1 condition
1 sponsor
1 location
NCT06303791
Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders
NA
Active, not recruiting
90 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05273970
Electrochemical and Electrophysiological Study
NA
Enrolling by invitation
10 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2027
2 conditions
3 sponsors
1 location
NCT05566847
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
NA
Active, not recruiting
817 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT05434481
MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta
NA
Active, not recruiting
60 participants
Started: Sep 7, 2022 · Completed: Oct 23, 2024
1 condition
2 sponsors
1 location
NCT05486559
The ECMO-Free Trial
NA
Enrolling by invitation
225 participants
Started: Sep 7, 2022 · Completed: Jul 1, 2027
1 condition
1 sponsor
8 locations
NCT05604495
Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
N/A
Recruiting
1,000 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05440643
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
PHASE1/PHASE2
Active, not recruiting
192 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
40 locations
NCT05534490
Surgery and Functionality in Older Adults
NA
Enrolling by invitation
70 participants
Started: Sep 6, 2022 · Completed: Nov 15, 2024
4 conditions
1 sponsor
1 location
NCT04522739
Spironolactone Safety in African Americans with Mild Cognitive Impairment and Early Dementia
PHASE4
Active, not recruiting
30 participants
Started: Sep 6, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT05288842
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
N/A
Recruiting
102 participants
Started: Sep 6, 2022 · Completed: Oct 31, 2026
2 conditions
6 sponsors
1 location
NCT05503082
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
PHASE4
Active, not recruiting
164 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2024
1 condition
2 sponsors
2 locations
NCT04987541
The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder
NA
Recruiting
60 participants
Started: Sep 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05598203
Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes
NA
Recruiting
252 participants
Started: Sep 6, 2022 · Completed: Oct 30, 2025
1 condition
1 sponsor
2 locations
NCT04927364
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
NA
Active, not recruiting
8 participants
Started: Sep 6, 2022 · Completed: Jul 1, 2025
2 conditions
2 sponsors
1 location
NCT05319132
Evaluate DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell From Subjects With ROSAH Syndrome
N/A
Recruiting
4 participants
Started: Sep 6, 2022 · Completed: May 6, 2028
1 condition
1 sponsor
5 locations
NCT05529251
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
PHASE2
Recruiting
90 participants
Started: Sep 6, 2022 · Completed: Sep 6, 2030
2 conditions
1 sponsor
15 locations
NCT06118567
Effect of Nitrous Oxide on Aggression.
PHASE2
Recruiting
50 participants
Started: Sep 6, 2022 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT05990179
Genomic Uniformed-Screening Against Rare Disease In All Newborns
NA
Recruiting
100,000 participants
Started: Sep 6, 2022 · Completed: Sep 30, 2029
1 condition
4 sponsors
1 location
NCT05371496
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
PHASE2
Enrolling by invitation
81 participants
Started: Sep 6, 2022 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT05423717
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
PHASE2
Recruiting
150 participants
Started: Sep 6, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
52 locations
NCT05534438
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
PHASE2
Recruiting
40 participants
Started: Sep 6, 2022 · Completed: Sep 6, 2026
6 conditions
1 sponsor
8 locations
Previous
1
More pages
1673
1674
1675
1676
1677
1678
1679
More pages
2369
Next